Please Note: This trial is no longer enrolling new participants
Follow-up Study for Subjects Enrolled on Genitope Protocol 2000-03 (IUPUI IRB protocol 0102-26) A Phase III Trial to Evaluate the Safety and Efficacy of Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH with GM-CSF, Compared to Non-Specific Immunotherapy, KLH With GM-CSF, In Patients with Follicular Non-Hodgkin's Lymphoma
| Protocol No. | CTO-IUSCCC-0779 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Michael Robertson | Treatment Type | Retrospective |
| Age Group | Adult | Phase | NA |
